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Abstract 
The Purpose of these studies was to investigate the ability of surface energy 
measurements and rates of mixing in dry powder inhaler formulations to predict aerosol 
dispersion performance. Two lactose carrier systems comprising either spray dried or 
milled particles were developed such that they had identical physical characteristics 
except for surface morphology and surface energies avoiding confounding variables 
common in other studies. Surface energy measurements confirmed significant differences 
between the powder systems. Spray dried lactose had a higher surface entropy (0.20 vs. 
0.13 mJ/m2K) and surface enthalpy (103.2 vs. 79.2 mJ/m2) compared to milled lactose. 
Mixing rates of budesonide or fluorescein were assessed dynamically and significant 
differences in blending were observed between lactose systems for both drugs. Surface 
energies of the lactose carriers were inversely proportional to dispersion performance. In 
addition, the root mean square of blending rates correlated positively with aerosol 
dispersion performance. Both techniques have potential utility in routine screening dry 
powder inhaler formulations.  
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Introduction 
The performance of dry powder inhalers (DPI) is highly dependent on the interactions of 
the device and the formulation components. In DPI formulations the active ingredient is 
micronized and most often blended with larger carrier particles, such as α-lactose 
monohydrate (Begat, Morton, Staniforth, & Price, 2004). The function of carrier particles 
within the DPI formulation is to aid flow, fluidization and dispersion properties(Hickey et 
al., 2007; Smyth & Hickey, 2005). Typical DPI formulations are binary mixtures of drug 
(1-5µm) and carrier particles smaller than 100µm (Larhrib, Zeng, Martin, Marriott, & 
Pritchard, 1999). It is known that for particle sizes of 10 μm diameter or less, 
gravitational forces acting on the particles transition to thermodynamic forces such as van 
der Waals forces between particles (Hickey, 2003). As a result, particles designed for 
inhalation (generally less than 5 μm) experience high degrees of cohesion. For this 
reason, the carrier particles are introduced into the system to modulate the interactive 
forces between drug particles. This type of formulation is termed an interactive mixture.  
 
Accordingly, the performance of interactive mixtures are controlled by relative 
magnitudes of cohesive (drug-drug) and adhesive (drug-excipient) interparticulate forces. 
On one hand, the ability to generate homogenous mixtures of drug and carrier particles 
will depend on the ability of the drug to adhere to the lactose carrier. Alternatively, the 
aerosol dispersion performance of the DPI formulation depends on the forces required to 
deaggregate and disperse drug particles from the carrier surface. For example, very strong 
adhesive forces may result in rapid and uniform mixing but may also prevent the release 
of the respirable drug particles from the carrier particles during inhalation (Hickey, 
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Concession, Van Oort, & Platz, 1994). Conversely, strong cohesive forces may cause 
particle segregation and heterogeneity during mixing but facilitate carrier-drug 
deaggregation during inhalation.  
 
Understanding and being able to predict interparticulate forces in DPI systems is a major 
focus of research, as this would lead to the ability to predict and optimize DPI 
performance. Interparticulate forces have been probed using a number of different 
approaches including the reductionist approach of looking at individual particle-particle 
interactions (e.g. atomic force microscopy), as well as composite and bulk powder 
methods utilizing powder flow indices and inverse gas chromatography (Bérard et al., 
2002; Louey, Mulvaney, & Stewart, 2001; Planinξek et al., 2003; Shekunov, Feeley, 
Chow, Tong, & York, 2003; M. D. Ticehurst, P. York, R. C. Rowe, & S. K Dwivedi, 
1996). So far, these methods have been either poor predictors of aerosolization behavior 
or are technically challenging to perform. We hypothesize that a simple direct approach 
of evaluating cohesive/adhesive forces in DPI formulations can be studied via mixing 
kinetics. It is proposed that temporal mixing behavior should correlate with the 
interparticulate forces between carrier and drug particles. Mixing studies, as routinely 
performed for blend uniformity validation, may therefore be employed as screening 
studies and predictors of powder performance in a passive DPI system.  
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Materials & Methods 
Materials 
 Lactose, both milled (Wyndale USP 100 Mesh) and spray dried (Super-Tab Spray 
Dried), were purchased from Lactose New Zealand (Lactose New Zealand, Hawera, New 
Zealand). Micronized Budesonide was purchased from Spectrum Chemicals and 
laboratory Products, New Brunswick, NJ USA. Fluorescein sodium was purchased from 
Sigma-Aldrich, St. Louis, MO USA. Acetonitrile (HPLC grade) was purchased from 
VWR, West Chester, PA USA. Gelatin capsules were obtained from Capsugel, 
Greenwood, SC, USA. Monobasic and dibasic potassium phosphate (HPLC grade) was 
purchased from VWR, West Chester, PA USA.  The alkane probes used for dispersive 
free energy determination were hexane (99+%, Aldrich), heptane (99+%, Aldrich), 
octane (99.5+%, Fluka), nonane (99+%, Aldrich), and decane (99+%, Aldrich). Polar 
probes used were tetrahydrofuron (THF) (EM Science, 99.99%), chloroform (100%, 
Mallinkrodt), acetone (99.7%, Mallinkrodt), ethyl acetate (99.9%, Mallinkrodt), diethyl 
ether (99%+, Acros), and ethanol (100%, Aaper).  
 
Lactose Carrier Preparation 
Significant preliminary and optimization studies were performed to obtain a method for 
generating comparable powder systems for both spray dried and milled lactose. Five 
grams of Lactose (spray dried or milled) was sieved with a sieve stack (425, 212, 125, 90, 
63 and 45µm mesh openings) using a Gilson Gilsonic Autosiever (Gilson Inc, Ohio, 
USA). The sieve was operated using a combination of tap and vibration modes for 2 
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minutes at a vibration amplitude of 40. The powder used as carrier lactose in subsequent 
studies was collected from the 63µm sieve and used in all studies below.   
 
Micronization 
Fluorescein sodium was micronized using a lab scale jet mill to reduce the particle size. 
The parameters used for milling were Pusher Pressure 100psi, Grinding 1 and Grinding 2 
Pressures at 100 and 110psi respectively. Particle size was verified using scanning 
electron microscopy. 
 
Blending 
20mg of micronized budesonide or fluorescein sodium was pre-blended with 0.98g of 
sieved lactose by geometrical addition and dilution in a 6ml vial. The total vial volume 
occupied by the powder was approximately 40%. Three replicates of each lactose type 
(spray dried & milled) with budesonide or fluorescein sodium were prepared. The rates 
and extent of blending were observed over time by sampling the blends at times up to 60 
minutes while being mixed using a Turbula orbital mixer at 42rpm (WAB, Switzerland). 
At each time point 4mg samples were taken from each of the vials (n=4) by micro-thief 
sampling at predetermined locations within the mixing vial. Samples were placed in 
HPLC vials containing 2ml mobile phase and drug content was analyzed using the HPLC 
method below. Blending uniformity was quantified and plotted by calculating percentage 
coefficient of variance (%CV) over time for each vial in the experimental matrix. Mixing 
rates were calculated by determining the slope of the blend uniformity curves. Due to the 
oscillation of blending rates in both the positive and negative direction (i.e. mixing and 
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segregation processes) we calculated the root mean square (RMS), also known as the 
quadratic mean, as the statistical measure of the magnitude of the varying quantity 
(mixing rates). The RMS enables quantification of the magnitude of the mixing rates 
deviation from zero. Simple averaging of the mixing rates is not applicable because both 
positive and negative mixing rates were obtained. RMS is a common method of 
quantifying signal amplitudes  in a variety of fields and is easily applied to the dynamics 
of the mixing of binary powders. This also allows direct comparison of the systems under 
investigation and description of the mixing process / dynamics using a single number.  
The RMS of variate x is given by the following formula: 
n
x
xR
n
i i∑== 1 2)(  
 
Dispersion and Powder Performance 
Dispersion and powder aerosolization performance was determined from cascade 
impaction studies as per USP/NF guidelines (USP 26, 2003) using a Next Generation 
Impactor (NGI) (MSP Corp, MN). Briefly, 20mg of blended powder from each vial 
containing lactose (spray dried or milled) and drug were placed in gelatin capsules and 
placed inside a Handihaler (Boehringer Ingelheim, Germany). The flow rate (60L/min) 
was pre-calibrated using a Gilmont Flowmeter Base Model F-4001 (Barnant Company, 
Barrington, IL, USA). The temperature during the study was 22ºC ± 1ºC and the relative 
humidity at 17% ± 2%.  
The fine particle dose (FPD) was determined as the mass of drug deposited in the 
NGI with aerodynamic diameters less than 4.6μm. Inertial impaction data was also 
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subjected to log-probability analysis to allow the derivation of mass median aerodynamic 
diameter (MMAD) and geometric standard deviation (GSD) for each aerosol powder 
dose (Feddah, Brown, Gipps, & Davies, 2000).  
 
Chemical Analysis 
Budesonide was analyzed according to the HPLC method reported by Gupta et al (Gupta 
& Bhargava, 2006). Briefly, HPLC was performed using a Hitachi Elite LaChrom 
(Hitachi, CA USA) with UV detection at 244nm using a Kromasil C8 column (150mm x 
4.6mm i.d., Column Engineering, CA USA). The mobile phase consisted of acetonitrile-
phosphate buffer (pH 3.2, 25mM, 55:45v/v) at a flow rate of 1.1ml/min, injection volume 
10µl and quantification was by peak area using a standard curve in the range 50µg/ml-
1µg/ml. HPLC analysis of fluorescein sodium was performed using the same column. 
UV detection was at 490nm and the mobile phase consisted of methanol:de-ionized water 
(60:40) at a flow rate of 1.0ml/min.  
 
Particle Size analysis of lactose  
Particle size characteristics of the lactose powders were determined using a Sympatec 
Helos laser diffraction instrument (Sympatec GmbH, Germany). Briefly sieved lactose 
(Spray dried & milled) was dispersed using compressed nitrogen gas at 150psi. The 
aerosol was drawn through the laser sensing region with a relative pressure of 95mbar 
using the Inhaler™ attachment and the detector was activated at a minimum optical 
concentration of between 4% and 5%. The size distribution was expressed by the volume 
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mean diameter (VMD). Morphology and particle size were also analyzed using S.E.M 
(JEOL 5800LV Scanning Electron Microscope) in low pressure mode. 
 
Surface Area analysis of lactose 
The surface area of sieved lactose (spray dried & milled) was determined using BET gas 
adsorption method. Powders were prepared under vacuum for 1 h at 40ºC and then 
analyzed using a Gemini Surface Area Analyzer (Micromeritics, Norcross, USA). 
Calculation of the specific surface area was done by the BET multipoint method. 
 
Surface Energy analysis of lactose 
Surface energy measurements were performed using the approach described by Telko 
and Hickey and does not assume the entropic contributions to Gibb’s free energy of 
adsorption can be neglected (Telko & Hickey, 2007).  Inverse gas chromatography (IGC) 
experiments were conducted with a Hewlett-Packard 5890 Series II GC equipped with 
flame ionization detector. The instrument was modified to allow installation of 205mm, 
4mm ID glass columns. Carrier gas employed was dry nitrogen at a flow rate of 
30mL/min. Oven temperatures used were 60oC, 48oC, 36oC, and 26oC. Previous 
experiments had shown that 60oC is the highest feasible temperature for analyzing 
lactose; prolonged exposure to higher temperatures can bring about polymorphic 
transitions. 26oC is the lowest temperature that can reliably be maintained in the GC oven 
used. Lactose was packed into deactivated (Mohammad & Fell, 1983) glass columns and 
plugged with silanated glass wool. After the temperature was changed, the packed 
column was allowed to equilibrate for 4 hours before subsequent injections were made. 
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Injections were made with a 1 μl-Hamilton syringe. Injection volumes were <0.01 μl; 
infinite dilution was ensured. Each injection was made at least 3 times and averaged; the 
relative standard deviations in the retention times of these injections were <1% in each 
case. Each batch was examined with two separate packed columns. Since even inert 
probes, such as methane, can be somewhat retarded (Smith, Haken, & Wainwright, 1978) 
dead-time was calculated using the retention times of heptane, octane, and nonane 
(Conder & Young, 1979).  
 
Thermal properties of lactose 
The thermal properties of sieved lactose (spray dried & milled) were analyzed using a 
modulated differential scanning calorimeter (Model 2920, TA instruments, New Castle, 
DE, USA). Samples of approximately 10mg were sealed in aluminum pans and scanned 
at a rate of 10ºC/min from 35 to 280ºC. The modulation signal was set at 1.592ºC/min. 
The thermograms were analyzed using TA instruments universal analysis software. 
 
Powder Flow and Density characteristics of lactose 
True density was measured using an Ultrapycnometer according to manufacturer’s 
directions (Quantachrome Instruments, Boynton Beach, FL, USA). Briefly, 2.5g of spray 
dried and milled lactose was added to the Ultrapycnometer and the true density analyzed 
using compressed helium at 17psi for 10 minutes. The average of six sample runs was 
performed. Powder flow characteristics were characterized using bulk/tap density, 
powder compressibility index, and Flodex measurements (Hansen Research, USA). 
Briefly, Flodex measurements involved adding approximately 20g of spray dried or 
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milled lactose into a chamber and the flow properties determined by the flow under 
gravity through various orifices of different size until all the powder passed through. 
 
Statistical Analysis 
All statistical analysis was performed using the paired student-t test with two-tailed 
comparison. Differences of p<0.05 are considered significantly different.  
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RESULTS 
Physical Properties 
The physical characterization of the lactose carrier systems confirmed equivalent particle 
size distributions, surface areas, true densities, and melting points of the spray dried and 
milled powders (Table 1).  The electron micrographs (Figure 1) show the different 
morphologies of milled lactose and spray dried lactose. Spray dried particles, as 
anticipated were spherical and milled lactose displayed monoclinic or tomahawk crystal 
shape.  
 
Surface Energies 
Dispersive surface free energy was calculated at each temperature based on the method of 
Schultz et al., 1987 (Schultz, Lavielle, & Martin, 1987). Plots of NVRT ln versus 
D
LA AN γ⋅⋅⋅2  were determined at each temperature (26oC, 36oC, 48oC, 60oC), and 
straight line was fitted to the data as described in Telko and Hickey(Telko & Hickey, 
2007) . The fit was excellent in each case (R2 > 0.999).  Table 2 shows the dispersive free 
energies determined at each temperature, and are in agreement with previous studies 
(Ahfat, Buckton, Burrows, & Ticehurst, 2000; Newell, Buckton, Butler, Thielmann, & 
Williams, 2001a, 2001b; Planinsek et al., 2003; M. D. Ticehurst, P. York, R. C. Rowe, & 
S. K. Dwivedi, 1996). The spray dried material has higher surface free energy at each 
temperature. Moreover, when the dispersive surface free energies are plotted against 
temperature for the materials (Figure. 2), different curves are obtained. The free energy of 
spray dried lactose increases more rapidly with temperature, resulting in a higher surface 
entropy (0.20 vs. 0.13 mJ/m2K) and surface enthalpy (103.2 vs. 79.2 mJ/m2). Clearly, 
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spray dried lactose is more energetic with respect to Lifschift-van der Waals forces. 
Interpretation of polar probes yields further insight. Differences in retention behavior of 
polar probes between spray dried and milled were evident throughout the analysis. The 
specific free energies obtained for each probe were plotted against temperature and 
enthalpies were calculated. The column to column reproducibility was very good and 
enthalpy values had RSD < 5% on all points. The enthalpies were used to obtain acidic 
and basic parameters, shown in Figure 3. KA and KB values obtained are 0.186 and 0.338 
for spray dried, and 0.159 and 0.235 for milled. The differences between spray dried and 
milled samples are evident with each probe and result in significantly different KA and 
KB values. Spray dried material is more energetic with higher acidic and basic 
parameters, and is thus expected to interact more strongly with acidic and basic 
molecules.  
 
Powder Flow 
The derived characteristics of these powders, powder compressibility (spray dried 
12.1%±0.26, milled 33.9%±0.14) and critical orifice measurements (Flodex) (spray 
dried=7, milled=22) indicated significantly better flow properties of spray dried lactose 
compared to milled lactose. 
 
Blending Dynamics   
Mixing rates of budesonide or fluorescein were assessed dynamically and significant 
differences in blending were observed between lactose systems for both drugs (Figures 4a 
and 4b). The mixing rates shown in figures 4a and 4b indicate the dynamic changes in the 
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coefficient of variation of samples taken from each powder system. For both drugs, 
milled lactose demonstrated the greatest dynamical change and variation in mixing and 
segregation rates. Spray dried lactose:budesonide formulations showed the least change 
in mixing rates. Also, we did not detect periods where powder segregation occurred with 
the spray dried lactose : budesonide formulations (all values were negative). In contrast, 
oscillating periods of mixing and segregation were observed for the milled 
lactose:budesonide powders. Similarly, the fluorescein experiments showed that the 
milled lactose had greater fluctuations from periods of mixing to periods of segregation 
compared to the spray dried lactose. We also characterized the average root mean square 
(RMS) of mixing for each powder system. This allows a single number to characterize 
the overall mixing dynamics for each drug and lactose combination. These data are 
presented below where correlations between mixing (RMS) and dispersion performance 
are described.  
 
Dispersion Studies 
Aerosol dispersion studies were performed to provide quantitative performance data for 
each drug:lactose combination and allows the predictive nature of both surface energy 
measurements and mixing studies to be determined. As expected, for both budesonide 
and fluorescein, the milled lactose system provides significantly improved performance 
over the spray dried system (Figure 5). This has been described previously and is thought 
to be related to the higher amorphous content in spray dried particles that may give rise to 
higher surface energies of spray dried particles (Louey, Van Oort, & Hickey, 2004; 
Newell et al., 2001a; Schiavone, Palakodaty, Clark, York, & Tzannis, 2004). It was also 
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noted that fluorescein aerosol dispersion efficiencies were significantly higher than that 
observed for budesonide. The poorer performing spray dried lactose, when used with 
fluorescein, had an equivalent fine particle dose to that of the higher performing milled 
lactose from the budesonide system.  
  
Figures 6a and 6b show the emitted doses from each formulation. No differences in 
emitted dose were detected, indicating that any differences in powder flow properties (i.e. 
fluidization of the powder from the inhaler) was not responsible for differences in 
dispersion efficiencies observed with the fine particle dose data. Despite the poorer flow 
performance of the milled lactose, the emitted dose from these formulations was the same 
as spray dried systems. In addition, the emitted doses were very similar between the two 
model drugs evaluated (budesonide and fluorescein) despite their very different fine 
particle dose efficiencies. This emphasizes the strong dependence of dispersion efficiency 
on interparticulate forces (drug:carrier) compared to low dependency on flow properties.  
 
Aerosolization Performance Correlates with Surface Energies and Mixing Dynamics 
Surface energies of the lactose carriers were inversely proportional to dispersion 
performance (Figure 7). As expected, there were significant differences in the correlation 
depending on the drug investigated.  Similar relationships between the fine particle dose 
and the Ka and Kb parameters were also evident (data not shown).  
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Fine particle dose was also related to the mixing behavior of each system (Figure 8). In 
this case, a positive correlation between the average RMS and log(FPD) was found. 
Increasing the RMS indicates greater fluctuations in mixing as a function of time.  
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Discussion 
The development of matched lactose carrier powder systems facilitated the investigation 
of surface energy and blending dynamics on aerosol performance under controlled 
conditions. Developing these matched DPI carrier systems was not a trivial task and has 
not been reported before. The most important differences between the spray dried and 
milled lactose powders was particle morphology and surface energetics. As expected 
spray dried particles were spherical and had higher surface energies. Milled particles of 
alpha-lactose monohydrate were more crystalline shape and had a corresponding lower 
surface energy . Differences in morphology and surface energies also corresponded to 
differences in powder flow measurements. Again, as expected, the spray dried particles 
had significantly improved flow performance as measured by Carr’s index and FloDex™ 
measurements. To minimize these differences in flow performance during the blending 
studies, we investigated the flow regimes of the powders within the mixing vessels at 
different speeds of the orbital mixer. The dynamic blending studies were performed at 
mixer speeds where the powder flow was observed to be in the cascading regime, thus 
minimizing the influence of flow performance differences during mixing. Blending 
dynamics were hypothesized to predict dispersion performance on the basis of cohesive 
and adhesive balances within binary mixtures. In general, the mixing kinetics showed the 
binary DPI mixtures underwent non-linear mixing. Budesonide mixing with spray dried 
lactose progressed via stepwise mixing rapidly. However, budesonide mixing with milled 
lactose demonstrated both mixing and segregation of the binary components as a function 
of time. Patterns of fluorescein mixing behavior with spray dried and milled lactose were 
less obvious. In both cases mixing and segregation intervals were identified. Milled 
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lactose had greater changes in mixing rates (i.e. more rapid mixing and segregation) 
compared to spray dried. These observations may be due to the significantly less adhesive 
forces between fluorescein and lactose as evidenced by the significantly higher fine 
particle dose of fluorescein aerosols compared to budesonide aerosols.  
 
The main objective of these studies was to investigate the predictive nature of 
both surface energy measurements and mixing dynamics for aerosol dispersion 
performance. Surface energy measurements were correlated negatively with dispersion 
performance, as predicted. Higher surface energies of the lactose powder systems 
resulted in lower dispersion efficiencies (as measured by fine particle dose) for both 
drugs tested. This was consistent for all surface energy quantification parameters 
(enthalpy, entropy, and acid and base contributions). Similar observations have been 
made previously between fine particle fraction and surface energy (Schiavone et al., 
2004). However, others have also reported a positive correlation between surface energy 
and fine particle fraction (Cline & Dalby, 2002). These different findings reported in IGC 
literature as it pertains to dry powder inhalation formulations exemplifies the difficulties 
in interpretation of correlations in these systems. If the powders that are being compared 
have different particle sizes, size distributions, surface areas, and other physical 
characteristics that are different, isolating the influence of surface energy on powder 
performances can be impossible. In these studies, we are confident that all these 
confounding variables (with the exception of particle morphology) have been well 
controlled and differences in powder performance can be strongly attributed to surface 
energetics. Further studies are underway using other drugs and additional matched lactose 
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systems to confirm this relationship. Surface energy determinations are quite labor 
intensive and the quantity of powder required is relatively large for accurate 
measurements. As a result there are limitations to the routine and high throughput 
screening of carrier systems for inhalation formulation development. Furthermore, 
surface energy measurements will generally only be applicable to the carrier system and 
not to the active agent due to sample size and cost considerations.  As a consequence, 
only one component of a binary dry powder inhalation formulation will be characterized, 
limiting the utility of the method.  
 
In contrast, mixing studies should be routinely performed during formulation 
development and may provide information on the interactions between both carrier and 
drug particles. We hypothesized that blending studies could be used to gain insight into 
the cohesive and adhesive balance between carrier and drug particles. Under this 
hypothesis, strong interactions between drug and carrier would be demonstrated during 
blending studies as rapid mixing. Alternatively, weak interactions between drug and 
carrier would result in either poor blending or oscillating periods of mixing and 
segregation. If blending studies were sensitive to these differences in interparticulate 
forces then they should also be a marker for aerosol dispersion performance. In these 
studies, we observed significant differences in blending behavior depending on both drug 
and lactose system. In particular, the root mean square of blending rates (i.e. both mixing 
and segregation rates) appeared to be predictive of aerosol dispersion performance. 
Increases in the RMS correlated with improved dispersion performance. Thus, greater 
mixing and segregation rates were associated with improved formulation performance. 
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This finding deviates somewhat from our original hypothesis. However, it appears that 
mixtures that have periods of both mixing and segregation at the time scales monitored 
(i.e. every 10 minutes up to 60 minutes) performed better. This observation is consistent 
with our original postulation that weak interactions between drug and carrier would result 
in either poor blending or oscillating periods of mixing and segregation. In terms of a 
screening method, blending studies should be routinely performed for formulation 
development independently of predicting aerosol performance. Consequently, blending 
studies are an attractive quantitative method to probe interactions between drug and 
carrier in dry powder inhaler formulations. We have initiated follow-up studies to utilize 
non-destructive chemical analysis (fiber optic probes in the mixing chamber) for faster 
real time monitoring of blending dynamics. It is possible the sensitivity of this technique 
will be significantly enhanced by improving both the temporal resolution and accuracy in 
powder sampling. In addition, we plan to evaluate the effect of differences in 
triboelectrification and electrostatic charge in different formulations being tested.  
 
Conclusion 
Under controlled conditions, the relationship between surface energy measurements and 
dispersion performance is, as anticipated, inversely proportional. However the 
relationship between mixing dynamics and dispersion performance was more complex. 
The observation of periods mixing and segregation in dry powder inhaler formulations 
during blending was positively correlated with aerosol dispersion performance. We 
quantified this by using the root mean square of mixing rates. Both surface energy 
measurements and blending studies may be used to predict dry powder inhaler 
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formulation performance. However, routine use of surface energy measurements via IGC 
may be limited by time and material constraints. In contrast, blending studies may be 
easily implemented for formulation screening, but further studies are required for 
confirmation.  
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Table 1. Physical characteristics of Spray dried and Milled Lactose 
 Spray dried Lactose Milled Lactose 
Particle Size (VMD) 69.83µm ± 0.21 70.23µm ± 0.45 
Surface Area 1.23 m2/g 1.21 m2/g 
True Density 1.54g/cm3± 0.00 1.50g/ cm3± 0.00 
Melting Point 
 
221.47±0.68 ºC 222.74±0.55ºC 
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Table 2. Dispersive Surface Free Energies (mean ± SD) 
 
Dispersive Surface Free Energy, mJ/m2 
T (oC) 
Milled Spray dried 
26 40.3 ± 0.04 43.0 ± 0.00 
36 38.8 ± 0.00 40.9 ± 0.54 
48 37.7 ± 0.06 38.8 ± 0.36 
60 35.7 ± 0.37 36.1 ± 0.50 
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A                   B  
Figure 1. Representative scanning electron micrographs of carrier particles (A: Lactose 
Milled; B: Lactose Spray dried), Scale bar is 200µm 
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Figure 2. Dispersive surface free energy of Spray dried (SD) and Milled (ML) lactose vs. 
temperature. The Spray dried material’s free energy varied more strongly with 
temperature, resulting in higher entropy and enthalpy values. 
 
 30
 
 
ML
y = 0.1591x + 0.2350
R2 = 0.9982
SD
y = 0.1857x + 0.3376
R2 = 0.9980
0
2
4
6
8
0 15 30 45DN/AN*
ΔH
sp
/A
N
*
 
Figure 3. Determination of KA and KB values from ΔHsp/AN*. Triangles represent Spray 
dried (SD) lactose; diamonds represent Milled (ML) lactose. Each point is average ± 
standard deviation. The best-fit lines pass through all points and clearly differentiate 
spray dried from milled material. The correlation is very strong in each case (R2≥0.998).  
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Figure 4a and 4b. Mixing rates determined throughout the blending experiment for both 
budesonide and fluorescein, using the milled and spray dried lactose carrier powders. 
Mixing and segregation rates are determined from the coefficients of variation of samples 
taken at each time point. Positive values indicate segregation while negative values 
correspond to mixing (n=3).  
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B 
Figure 5. Average Fine Particle Dose (FPD) of micronized budesonide (A) and 
fluorescein (B) from Milled and Spray dried Lactose (n=9) 
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Figure 6a and 6b. Emitted dose characteristics for each powder blend (n=9). 
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Figure 7. Fine particle dose as a function of surface enthalpy for each formulation type. 
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Figure 8. Log of the fine particle dose as a function of the average RMS of mixing rates.  
 
